Filter
1789
Filtered Results: 1789
Text search:
tb
costs
Featured
Recommendations
163
New Publications
538
Language
Document type
No document type
1165
Studies & Reports
257
Guidelines
185
Manuals
63
Strategic & Response Plan
63
Fact sheets
21
Training Material
15
Situation Updates
9
Infographics
7
Resource Platforms
3
Brochures
1
Countries / Regions
India
85
Kenya
81
Global
62
South Africa
61
Western and Central Europe
50
Zambia
42
Ethiopia
40
Africa
39
Uganda
38
Malawi
34
Nepal
31
Tanzania
31
Eastern Europe
30
Nigeria
29
Liberia
29
Myanmar / Burma
29
Sierra Leone
27
Rwanda
26
Latin America and the Carribbean
26
Ghana
24
Bangladesh
22
Namibia
22
Cambodia
20
Ukraine
19
South–East Asia Region
19
Asia
18
Lesotho
17
Zimbabwe
15
Philippines
14
Botswana
13
East and Southern Africa
12
Mozambique
11
Indonesia
9
Syria
8
Senegal
8
Congo, Democratic Republic of
7
South Sudan
7
Pakistan
7
Haiti
6
West and Central Africa
6
Russia
6
Georgia
6
Colombia
5
Benin
5
Guinea
5
Germany
5
Middle East and North Africa
5
Vietnam
5
Albania
4
Western Pacific Region
4
Timor Leste/ East Timor
3
Thailand
3
Cameroon
3
Laos
3
Burkina Faso
3
Armenia
3
Jordan
3
North America
3
Southern Africa
3
Sudan
3
Tajikistan
2
Iran
2
Peru
2
Venezuela
2
Eastern Europe and Central Asia
2
Argentina
2
Lebanon
2
Papua New Guinea
2
Brazil
2
Moldova
2
Sri Lanka
2
Central African Republic
2
Poland
2
Iraq
2
Eswatini/ Swaziland
2
North Macedonia
1
North Korea
1
Serbia
1
China
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
Morocco
1
Bulgaria
1
USA
1
Hungary
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
Maldives
1
Tunisia
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Yemen
1
Romania
1
Greece
1
Angola
1
Chad
1
Bhutan
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
740
Clinical Guidelines
135
Public Health
87
Key Resources
45
Women & Child Health
43
Pharmacy & Technologies
23
Capacity Building
17
Annual Report MEDBOX
2
Toolboxes
TB
331
HIV
247
AMR
80
COVID-19
55
Mental Health
43
NTDs
36
Pharmacy
35
Caregiver
34
Global Health Education
32
Health Financing Toolbox
28
NCDs
26
Disability
25
Refugee
24
Planetary Health
22
Conflict
19
Polio
16
Rapid Response
13
Natural Hazards
13
Ebola
13
Social Ethics
5
Specific Hazards
2
Zika
2
South Sudan
1
Cholera
1
Health Financing
1
Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
Single TB and HIV Concept Note Albania 2016-2018 27 April 2015
Accessed: 19.10.2019
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; challenges in health systems that influence TB care; ...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...
The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
